All subcategories » published RCT
Improved residual fat malabsorption and growth in children with cystic fibrosis treated with a novel oral structured lipid supplement: A randomized controlled trial.
primary studies published RCT
Details- 2020
- Stallings VA
Correction: Improved residual fat malabsorption and growth in children with cystic fibrosis treated with a novel oral structured lipid supplement: A randomized controlled trial.
primary studies published RCT
Details- 2020
- Stallings VA
Effects of low glycemic index/high-fat, high-calorie diet on glycemic control and lipid profiles of children and adolescence with cystic fibrosis: A randomized double-blind controlled clinical trial.
primary studies published RCT
Details- 2020
- Gorji Z
Effects of synbiotic supplementation on the pulmonary manifestations and anthropometric measurements in children with cystic fibrosis- a randomized clinical trial
primary studies published RCT
Details- 2020
- N Bilan, E Marefat, M Nouri-Vaskeh, L Nikniaz, Z Nikniaz
Efficacy and safety of ataluren in patients with nonsense-mutation cystic fibrosis not receiving chronic inhaled aminoglycosides: The international, randomized, double-blind, placebo-controlled Ataluren Confirmatory Trial in Cystic Fibrosis (ACT CF).
primary studies published RCT
Details- 2020
- Konstan MW
A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis.
primary studies published RCT
Details- 2020
- McWilliam SJ
CFTR activity is enhanced by the novel corrector GLPG2222, given with and without ivacaftor in two randomized trials.
primary studies published RCT
Details- 2019
- Bell SC
Non-invasive ventilation versus oxygen therapy in cystic fibrosis: A 12-month randomized trial.
primary studies published RCT
Details- 2019
- Milross MA
Lumacaftor/Ivacaftor reduces pulmonary exacerbations in patients irrespective of initial changes in FEV1.
primary studies published RCT
Details- 2019
- McColley SA
Impact of hypertonic saline nebulisation combined with oscillatory positive expiratory pressure on sputum expectoration and related symptoms in cystic fibrosis: a randomised crossover trial.
primary studies published RCT
Details- 2019
- San Miguel-Pagola M